Clinical Trials Browser

Phase 2/3 × Completed × Celecoxib × Clear all

Adenoma, Digestive System Diseases, Digestive System Neoplasms, Duodenal Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplastic Syndromes, Hereditary, Adenomatous Polyposis Coli, Polyps, Adenomatous Polyps, Genetic Diseases, Inborn

NCT00006124 2013-02-13

Celecoxib in Treating Patients With Bladder Cancer

Phase 2/3 Completed

152 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT00136487 2009-12-09

Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer

Phase 2/3 Completed

85 enrolled

Genitourinary

Prostatic Neoplasms

Clinical Trials

PreDuoFAP

Celecoxib in Treating Patients With Bladder Cancer

Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer